Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma

Journal article

Open access

Peer reviewed

Respiratory Medicine, Vol.191

2022

Abstract

Benralizumab

Indirect treatment comparison

Matching-adjusted indirect comparison

Mepolizumab

Severe eosinophilic asthma

Dupilumab

url

Find in HALView

url

https://doi.org/10.1016/j.rmed.2020.105999View

Published (Version of record) Open

1 Record Views

Title: Non-optimal methodology questions indirect treatment comparison of dupilumab vs. other biologics in severe asthma
Creators - without role: Arnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Nicolas Molinari - Université de Montpellier, Institut Montpelliérain Alexander Grothendieck - IMAG
Publication Details: Respiratory Medicine, Vol.191
Identifiers: 9944479309311
Academic Unit: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp; Institut Montpelliérain Alexander Grothendieck - IMAG
Language: English
Resource Type: Journal article
Local Fields: hal-03548301